CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 51 enrolled
Drug / intervention
Sevoflurane +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02918877
NCT02918877Phase 2Completed
CompareCT.gov

Anesthetics to Prevent Lung Injury in Cardiac Surgery

Beth Israel Deaconess Medical Center·interventional·Posted Sep 29, 2016·Updated May 5, 2021

In Brief

A Phase 2 clinical trial evaluating Sevoflurane and Propofol for Inflammatory Lung Injury and 2 related conditions. Completed, enrolled 51 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate whether the use of inhaled anesthetics, compared to intravenous anesthetics, can affect the amount of lung inflammation and postoperative respiratory complications seen after cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Lung Injury, Ischemia-Reperfusion Lung Injury, Postoperative Pulmonary Complications
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 29, 2016
Enrollment StartJun 9, 2017
Primary CompletionDec 24, 2018
Study CompletionFeb 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.8 years ago

Interventions

Sevofluranedrug

Volatile Anesthetic

Propofoldrug

Intravenous Anesthetic